You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Is your feature request related to a problem? Please describe.
Implement PP3 and BP4 criteria
Describe the solution you'd like
Investigate
Make plan
Describe alternatives you've considered
N/A
Additional context
PP3
PP3 (in silico predictions)
Original Definition
Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc).
Caveats:
- As many in silico algorithms use the same or very similar input for their predictions, each algorithm should not be counted as an independent criterion.
- PP3 can be used only once in any evaluation of a variant.
-- Richards et al. (2015); Table 4
Preconditions / Precomputations
If the criterion PVS1 was triggered then this criterion is skipped.
If the variant is on chrMT then it is skipped, as we don't have calibration for chrMT yet.
If the variant is not found in dbNSFP or CADD precomputed scores then it is skipped as we don't have calibration for chrMT yet.
Implemented Criterion
An initial prediction is fist done using the general purpose pathogenicity predictors.
If we have a score from the following, then the prediction is used (in descending order of priority):
we will use the modifiers from :footcite:t:pejaver:2022
If predictions are missing then then PhyloP of the position of the variant is used as a fallback.
Then, for splicing the following is done.
If a SpliceAI prediction is performed then it is interpreted according to :footcite:t:walker:2023.
The highest-scoring variant is used for the final prediction.
User Report
The scores and predictions from the predictors.
Caveats
As described in :ref:acmg_seqvars_criteria-patho-predictions, we are currently limited to the precomputed threshold from the literature.
This hinders us in adopting AlphaMissense effectively, for example.
We need to compute accuracy to rank the implemented methods.
We need our own calibration for chrMT.
Notes
This criterion is similar to :ref:acmg_seqvars_criteria-bp4
BP4
BP4 (in silico predictions)
.. note::
- we have not implemented MitoTip or MitImpact yet
- we are lacking phylop scores yet
- we don't have live CADD scores yet
Original Definition
Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc).
Caveat: As many in silico algorithms use the same or very similar input for their predictions, each algorithm cannot be counted as an independent criterion.
BP4 can be used only once in any evaluation of a variant.
-- Richards et al. (2015); Table 4
Preconditions / Precomputations
If the criterion BA1 triggered then this criterion is skipped.
If the variant is on chrMT then it is skipped, as we don't have calibration for chrMT yet.
If the variant is not found in dbNSFP or CADD precomputed scores then it is skipped as we don't have calibration for chrMT yet.
Implemented Criterion
See :ref:acmg_seqvars_criteria-pp3 for details.
User Report
See :ref:acmg_seqvars_criteria-pp3 for details.
Literature
See :ref:acmg_seqvars_criteria-pp3 for details.
Caveats
See :ref:acmg_seqvars_criteria-pp3 for details.
Notes
This criterion is similar to :ref:acmg_seqvars_criteria-pp3
Intervar
Intervar
PP3 and BP4 by Automated Scoring
When multiple pieces of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.), then the supporting pathogenic evidence of PP3 will be assigned as 1. In comparison, when multiple pieces of computational evidence suggest no impact on the gene or gene product, then supporting benign evidence of BP4 will be assigned as 1. All sets of in silico results must agree when PP3 or BP4 is assigned.
These multiple pieces of computational evidence can be provided by ANNOVAR from the “dbnsfp30a” database, where the MetaSVM score16 is used for deleteriousness prediction and GERP++ is used for evolutionary conservation. The splicing impacts can be inferred by ANNOVAR from the “dbscsnv11” database. For the evidence of PP3 and BP4, we set the cutoff to 0.0 for MetaSVM scores (greater scores indicate more likely deleterious effects), 2.0 for GERP++_RS (smaller scores indicate less conservation), and 0.6 for adaptive boosting (ADA) and random forest (RF) scores of dbscSNV as splicing impact (larger scores indicate more likely splice altering).
The text was updated successfully, but these errors were encountered:
Is your feature request related to a problem? Please describe.
Implement
PP3
andBP4
criteriaDescribe the solution you'd like
Describe alternatives you've considered
N/A
Additional context
PP3
PP3 (in silico predictions)
Original Definition
Preconditions / Precomputations
Implemented Criterion
An initial prediction is fist done using the general purpose pathogenicity predictors.
pejaver:2022
Then, for splicing the following is done.
walker:2023
.The highest-scoring variant is used for the final prediction.
User Report
Caveats
acmg_seqvars_criteria-patho-predictions
, we are currently limited to the precomputed threshold from the literature.This hinders us in adopting AlphaMissense effectively, for example.
Notes
acmg_seqvars_criteria-bp4
BP4
BP4 (in silico predictions)
.. note::
Original Definition
Preconditions / Precomputations
Implemented Criterion
See :ref:
acmg_seqvars_criteria-pp3
for details.User Report
See :ref:
acmg_seqvars_criteria-pp3
for details.Literature
See :ref:
acmg_seqvars_criteria-pp3
for details.Caveats
See :ref:
acmg_seqvars_criteria-pp3
for details.Notes
acmg_seqvars_criteria-pp3
Intervar
Intervar
PP3 and BP4 by Automated Scoring
When multiple pieces of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.), then the supporting pathogenic evidence of PP3 will be assigned as 1. In comparison, when multiple pieces of computational evidence suggest no impact on the gene or gene product, then supporting benign evidence of BP4 will be assigned as 1. All sets of in silico results must agree when PP3 or BP4 is assigned.
These multiple pieces of computational evidence can be provided by ANNOVAR from the “dbnsfp30a” database, where the MetaSVM score16 is used for deleteriousness prediction and GERP++ is used for evolutionary conservation. The splicing impacts can be inferred by ANNOVAR from the “dbscsnv11” database. For the evidence of PP3 and BP4, we set the cutoff to 0.0 for MetaSVM scores (greater scores indicate more likely deleterious effects), 2.0 for GERP++_RS (smaller scores indicate less conservation), and 0.6 for adaptive boosting (ADA) and random forest (RF) scores of dbscSNV as splicing impact (larger scores indicate more likely splice altering).
The text was updated successfully, but these errors were encountered: